The first one, Fight Cancer contributes to society concerned matter, it is a project that personally affects each and every one of us. Producing medical isotopes to advance cancer treatment and save lives is Framatome Healthcare's mission. Medical isotopes are used to diagnose and treat primary and metastatic tumors by destroying cancer cells without impacting healthy tissues.
Our system allows the production of vital medical isotopes in existing nuclear reactors. This system, based in Canada, has been producing weekly batches of medical isotopes since November 2022, which are then transported to our pharmaceutical partner in Germany, where they are prepared to treat cancer patients in hospitals around the world.
Through Framatome Healthcare, we plan to go even further: installing the isotope production system at nuclear power plants around the world to treat more than one million cancer patients over the next five years.
Fight Cancer has been awarded in 2023 by TIP Awards and by EDF at the EDF Pulse innovation contest. Framatome Healthcare teams are eager to continue this path with EDF because «EPR technology is very suitable for the installation of a medical Isotope Production System» according to François Gauché, Framatome Healthcare Director.
Congratulations to the Framatome teams and their partners Bruce Power, ITM Isotope Technologies Munich SE, Isogen and Kinectrics. Now, with the Isotope Production System, nuclear power can go a step further – to save lives of cancer patients worldwide. Let’s fight cancer together!
Luc Rémont, CEO of EDF and the Fight Cancer team with Curtis Van Cleve, Umar Faraz, Erik Van Lier, Sven Wegener
Find out more :
- Video: presentation of the Fight Cancer project
- Video: New Isotope Production System at Bruce Power
- About Framatome Healthcare
The 2nd innovation QUANTOM revolutionizes the control of nuclear waste with a mobile and automated measurement system that analyzes its contents without opening them.
QUANTOM helps to avoid opening waste drums without the need for repackaging and without increasing the volume of waste. The measurement process from 2h to 4h per barrel is very fast and precise: elemental analysis detecting up to 1 ppm (~ 1 mg per kg). This system minimizes radiation exposure of operating personnel and the transport of radioactive waste while reducing costs (min. 50%) compared to traditional methods. Thousands of drums could benefit from this non-destructive analysis in Western Europe and South Korea in nuclear and other non-electronuclear sectors such as research, defense and medical.
QUANTOM has been awarded over the past 12 months by the European Commission and EDF during the EDF Pulse innovation contest. By awarding this award in the “Low Carbon Production” category, EDF is looking to QUANTOM for a promising future.
Congratulations to Framatome teams and their partners: AINT GmbH, Fraunhofer INT, the German Ministry of Research and Education. .
Xavier Ursat, Group Executive Director in charge of Engineering and New Nuclear Projects and the QUANTOM team : Xavier Ursat, Laurent Coquard, Hauke Grages
Find out more: